| Generic APIs (GDS) | Manufacturing and sale of bulk generic active pharmaceutical ingredients across 10 therapeutic areas. | Longstanding manufacturing expertise, regulatory approvals (USFDA, EMA), and robust global DMF portfolio. | B2B focus serving generic pharmaceutical companies worldwide. | Complex specialty APIs and peptides yielding higher margins. | 700 | 47 | Sales revenue from global API sales to generic drug manufacturers and distributors. | Contractual sales based on volume and long-term agreements. | Demand for generic APIs, expanding regulatory approvals, and process innovation. | Salbutamol Sulphate, Terbutaline Sulphate, Ciprofloxacin, Itraconazole, Ramipril |
| Contract Development and Manufacturing Organization (CDMO) Services (CMS) | Custom development, clinical to commercial supply of APIs and intermediates for innovator pharmaceutical companies. | Strong R&D capabilities, intellectual property, regulatory compliance, and trusted partnership status with key clients. | B2B service provider for innovator pharma companies developing new drugs. | Peptide APIs, new chemical entities, and specialized intermediates. | 680 | 46 | Revenue from development and manufacturing contracts, milestone payments, and clinical supply agreements. | Project-based contracts with recurring manufacturing orders post commercialisation. | Increasing outsourcing by innovators, peptide API demand, and advanced capabilities in complex syntheses. | Peptide APIs, Novel Chemical Entities (NCEs) under development |
